GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AdAlta Ltd (ASX:1AD) » Definitions » Policy Acquisition Expense

AdAlta (ASX:1AD) Policy Acquisition Expense


View and export this data going back to 2016. Start your Free Trial

What is AdAlta Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


AdAlta (ASX:1AD) Business Description

Industry
Traded in Other Exchanges
N/A
Address
2 Park Drive, Unit 15, Bundoora, VIC, AUS, 3083
AdAlta Ltd is engaged in drug discovery and development company developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis, and CAR-T cancer therapeutics.